- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00679406
Brief Behavioral Treatment of Insomnia in Military Veterans: Phase 1 (BBTIMV1)
June 15, 2012 updated by: Anne Germain, University of Pittsburgh
Treatment of Insomnia in Military Veterans:Phase 1
The purpose of this study is to adapt and test the effects of a 4-week behavioral treatment that targets chronic insomnia (lasting >1 month) in service members returning from Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Insomnia is one of the most common reasons for referral to mental health services in active duty personnel.
Chronic insomnia often persists post-deployment, contributes to poor mental and physical health outcomes, and requires targeted interventions.
Effective behavioral treatments of insomnia have not been adapted and tested for the treatment of chronic insomnia comorbid to combat-related mental disorders and stress reactions.
In addition, effective behavioral insomnia treatments are typically delivered over an 8-week period.
This format may not be easily exportable to primary and community care settings where military returnees and veterans seek help.
The goal of this R34 Exploratory Clinical Research Grant is to adapt and test the effects of a 4-week behavioral treatment that targets chronic insomnia (lasting >1 month) in service members returning from Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF), and who present with the typical psychiatric comorbidities associated of combat-related anxiety and mood disorders and stress reactions.
We call this intervention the Brief Behavioral Treatment of Insomnia for Military Veterans (BBTI-MV).
The proposed study includes two phases.
Phase I aims at iteratively adapting and refining a treatment manual for insomnia in OIF/OEF military returnees.
Outcomes of interest include self-report, diary, and actigraphic sleep measures, as well as measures of PTSD, anxiety, and depression, and perceived physical health.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- Western Psychiatric Institute and Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age is 18 and older.
- Military returnees from OIF/OEF
Meet diagnostic criteria for chronic insomnia as defined by:
- a. Complaint of sleep latency >30 minutes, or wake time after sleep onset >30 minutes, or Sleep Efficiency <85%, or a complaint of non-restorative sleep;
- b. Frequency of insomnia complaint >3 times per week;
- c. Duration of insomnia complaint >1 month
- d. Associated with at least one daytime consequences
- If using sleep medications, medication and dosage have not been changed in the past month, and will remain unchanged for the duration of the acute treatment phase of the study (i.e., 4 weeks)
- If using other psychotropic medications, medication and dosage have not been changed in the past 2 months, and will remain unchanged for the duration of the acute treatment phase of the study (i.e., 4 weeks)
Exclusion Criteria:
- Active duty personnel, or reservists/national guards scheduled for re-deployment over the following eight months
- Untreated, current, and severe PTSD as determined on the SCID.
- Untreated, current, and severe Major Depressive Disorder as determined by the Structured Clinical Interview for DSM-IV and a score > 30 on the Beck Depression Inventory
- Psychotic or bipolar disorder
- Current substance or alcohol use disorder as determined by the SCID or by positive drug toxicology results
- Unstable medical condition
- Hospitalization in the previous 2 weeks for a medical condition or surgery for which recovery overlaps with the study onset and duration
- Seizure disorder or traumatic brain injury.
- Current sleep disorders such as nightmare disorder, restless legs syndrome, or suspected sleep disorder requiring polysomnographic assessment, such as obstructive sleep apnea or periodic leg movements.
- Sleep apnea revealed during the screening sleep study.
- Pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Brief Behavioral Treatment for Insomnia
|
Effective behavioral insomnia treatments are typically delivered over an 8-week period.
This format may not be easily exportable to primary and community care settings where military returnees and veterans seek help.
The goal here is to test the effects of a 4-week behavioral treatment that targets chronic insomnia (lasting >1 month) in service members returning from Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF), and who present with the typical psychiatric comorbidities associated of combat-related anxiety and mood disorders and stress reactions.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pittsburgh Sleep Diary
Time Frame: Weekly during entire participation
|
Weekly during entire participation
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Baseline and Post Intervention
|
Baseline and Post Intervention
|
PSQI Addendum for PTSD (PSQIA)
Time Frame: Baseline and Post Intervention
|
Baseline and Post Intervention
|
Sleep quality defined by:PIRS 20 and the ISI
Time Frame: Screening, Baseline, and Post Intervention
|
Screening, Baseline, and Post Intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
PTSD symptom severity as measured by the CAPS
Time Frame: Screening
|
Screening
|
Depression: BDI
Time Frame: Baseline and Post Intervention
|
Baseline and Post Intervention
|
Anxiety: BAI
Time Frame: Baseline and Post Intervention
|
Baseline and Post Intervention
|
Medical History: MHQ, MEDHIST_2WK, MOS
Time Frame: Screening, Baseline, and Post Intervention
|
Screening, Baseline, and Post Intervention
|
Trauma History: THQ,CES,PCL-C,ICG
Time Frame: Screening, Baseline, and Post Intervention
|
Screening, Baseline, and Post Intervention
|
Post Sleep Self Report: PSEQ-SV and POST
Time Frame: Screening
|
Screening
|
Sleepiness: EPWORTH, BASS
Time Frame: Screening, Baseline, and Post Intervention
|
Screening, Baseline, and Post Intervention
|
Expectations and Satisfaction: TEQ-94, Client Satisfaction Survey
Time Frame: Baseline and Post Intervention
|
Baseline and Post Intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Anne Germain, PhD., University of Pittsburgh, Department of Psychiatry
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2008
Primary Completion (Actual)
April 1, 2009
Study Completion (Actual)
April 1, 2009
Study Registration Dates
First Submitted
May 14, 2008
First Submitted That Met QC Criteria
May 15, 2008
First Posted (Estimate)
May 16, 2008
Study Record Updates
Last Update Posted (Estimate)
June 18, 2012
Last Update Submitted That Met QC Criteria
June 15, 2012
Last Verified
June 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO07110063
- NIMH: 1 R34 MH080696
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Insomnia
-
University of AarhusTrygFonden, Denmark; Enversion A/SActive, not recruiting
-
Posit Science CorporationCompletedInsomnia ChronicUnited States
-
Jun SongUnknown
-
University of ManitobaCompleted
-
University of Missouri-ColumbiaUniversity of FloridaCompleted
-
University of AarhusTrygFonden, Denmark; Enversion A/SCompleted
-
University of TromsoUniversity Hospital of North Norway; Diakonhjemmet HospitalNot yet recruitingPain, Chronic | Insomnia Chronic | Insomnia Due to Medical ConditionNorway
-
University of Missouri-ColumbiaCompletedPain, Chronic | Insomnia ChronicUnited States
-
Diakonhjemmet HospitalActive, not recruitingSleep Disorder | Insomnia | Sleep Initiation and Maintenance Disorders | Chronic Disease | Sleep Disturbance | Insomnia Chronic | Insomnia Due to Medical Condition | Insomnia, PsychophysiologicalNorway
Clinical Trials on Brief Behavioral Treatment for Insomnia
-
Brigham and Women's HospitalRecruiting
-
VA Pittsburgh Healthcare SystemVA Office of Research and DevelopmentCompleted
-
National Cheng-Kung University HospitalRecruitingOlder Adults | Chronic Insomnia | Sleep HygieneTaiwan
-
VA Pittsburgh Healthcare SystemCompletedInsomnia | Treatment Resistant DepressionUnited States
-
State University of New York at BuffaloNational Institute of Nursing Research (NINR); Roswell Park Cancer InstituteCompleted
-
VA Office of Research and DevelopmentUniversity of California, San FranciscoCompleted
-
Hospital General de MexicoEnrolling by invitationDepression | Anxiety | Sleep Quality | Insomnia Chronic | Life QualityMexico
-
University of California, San DiegoWithdrawnStage, Breast CancerUnited States
-
VA Office of Research and DevelopmentRecruitingBrief Behavioral Treatment for Insomnia in Veterans With Posttraumatic Stress Disorder (BBTI & PTSD)Posttraumatic Stress Disorder | Insomnia DisorderUnited States
-
Nagoya City UniversityKochi UniversityCompletedMajor Depressive DisorderJapan